Cesca Therapeutics Inc.

Cesca Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
20.65 M
Public Float
4.61 M
Cesca Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$22.5
Market Cap
$7.92 M
Shares Outstanding
20.65 M
Public Float
4.61 M

Profile

Address
2711 Citrus Road
Rancho Cordova California 95742
United States
Employees -
Website http://www.cescatherapeutics.com
Updated 07/08/2019
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets.

Financials

View All

Xiao Chun Xu
Chairman, President & Chief Executive Officer
Vivian H. Liu
Chief Operating Officer, Secretary & Director